{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T16:33:40Z","timestamp":1793291620575,"version":"4.5.0"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Prostate Cancer Prostatic Dis"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1038\/s41391-026-01139-y","type":"journal-article","created":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T14:44:56Z","timestamp":1787582696000},"page":"1005-1012","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prostate size and its effect on sexual function following convective water vapor thermal therapy"],"prefix":"10.1038","volume":"29","author":[{"given":"Amandip","family":"Cheema","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bronwyn","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Owen","family":"Lewer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Copelan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarang","family":"Janakiraman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Wozniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0755-0772","authenticated-orcid":false,"given":"Kevin T.","family":"McVary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,24]]},"reference":[{"key":"1139_CR1","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1097\/JU.0000000000000499","volume":"203","author":"C Welliver","year":"2020","unstructured":"Welliver C, Feinstein L, Ward JB, Fwu C-W, Kirkali Z, Bavendam T, et al. Trends in lower urinary tract symptoms associated with benign prostatic hyperplasia, 2004 to 2013: the Urologic Diseases in America Project. J Urol. 2020;203:171\u20138.","journal-title":"J Urol"},{"key":"1139_CR2","unstructured":"US Food and drug Administration. 510(k) Premarket Notification K150786. FDA; 2025."},{"key":"1139_CR3","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1016\/j.urology.2015.05.046","volume":"86","author":"C Dixon","year":"2015","unstructured":"Dixon C, Cedano ER, Pacik D, Vit V, Varga G, Wagrell L, et al. Efficacy and safety of rezum system water vapor treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia. Urology. 2015;86:1042\u20137. https:\/\/doi.org\/10.1016\/j.urology.2015.05.046.","journal-title":"Urology"},{"key":"1139_CR4","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1097\/JU.0000000000001778","volume":"206","author":"KT McVary","year":"2021","unstructured":"McVary KT, Gittelman MC, Goldberg KA, Patel K, Shore ND, Levin RM, et al. Final 5-year outcomes of the multicenter randomized sham-controlled trial of a water vapor thermal therapy for treatment of moderate to severe lower urinary tract symptoms secondary to benign prostatic hyperplasia. J Urol. 2021;206:715\u201324. https:\/\/doi.org\/10.1097\/JU.0000000000001778.","journal-title":"J Urol"},{"key":"1139_CR5","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/sj.ijir.3900472","volume":"11","author":"RC Rosen","year":"1999","unstructured":"Rosen RC, Cappelleri J, Smith M, Lipsky J, Pena B. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res. 1999;11:319\u201326.","journal-title":"Int J Impot Res"},{"key":"1139_CR6","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1016\/j.eururo.2011.07.053","volume":"60","author":"RC Rosen","year":"2011","unstructured":"Rosen RC, Allen KR, Ni X, Araujo AB. Minimal clinically important differences in the erectile function domain of the International Index of Erectile Function scale. Eur Urol. 2011;60:1010\u20136.","journal-title":"Eur Urol"},{"key":"1139_CR7","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.juro.2016.11.044","volume":"197","author":"SA Kaplan","year":"2017","unstructured":"Kaplan SA. Drug adherence and clinical outcomes for patients under pharmacological therapy for lower urinary tract symptoms related to benign prostatic hyperplasia: population-based cohort study. J Urol. 2017;197:483\u20134.","journal-title":"J Urol"},{"key":"1139_CR8","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/j.eururo.2014.12.038","volume":"67","author":"C Gratzke","year":"2015","unstructured":"Gratzke C, Bachmann A, Descazeaud A, Drake MJ, Madersbacher S, Mamoulakis C, et al. EAU guidelines on the assessment of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol. 2015;67:1099\u2013109.","journal-title":"Eur Urol"},{"key":"1139_CR9","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1016\/j.euf.2022.06.007","volume":"8","author":"C Manfredi","year":"2022","unstructured":"Manfredi C, Garcia-Gomez B, Arcaniolo D, Garcia-Rojo E, Crocerossa F, Autorino R, et al. Impact of surgery for benign prostatic hyperplasia on sexual function: a systematic review and meta-analysis of erectile function and ejaculatory function. Eur Urol Focus. 2022;8:1711\u201332.","journal-title":"Eur Urol Focus"},{"key":"1139_CR10","doi-asserted-by":"crossref","unstructured":"Reich O, Gratzke C, Stief CG. Techniques and long-term results of surgical procedures for benign prostatic hyperplasia. Eur Uro. 2006;49:970\u20138.","DOI":"10.1016\/j.eururo.2005.12.072"},{"key":"1139_CR11","doi-asserted-by":"crossref","unstructured":"McVary KT, Rademaker A, Lloyd GL, Gann P. Autonomic nervous system overactivity in men with lower urinary tract symptoms secondary to benign prostatic hyperplasia. J Urol. 2005;174:1327\u201333.","DOI":"10.1097\/01.ju.0000173072.73702.64"},{"key":"1139_CR12","doi-asserted-by":"crossref","unstructured":"Thorve VS, Kshirsagar AD, Vyawahare NS, Joshi VS, Ingale KG, Mohite RJ. Diabetes-induced erectile dysfunction: epidemiology, pathophysiology and management. J Diabetes Complications. 2011;25:129\u201336.","DOI":"10.1016\/j.jdiacomp.2010.03.003"}],"container-title":["Prostate Cancer and Prostatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41391-026-01139-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41391-026-01139-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41391-026-01139-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T16:03:40Z","timestamp":1793289820000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41391-026-01139-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":12,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["1139"],"URL":"https:\/\/doi.org\/10.1038\/s41391-026-01139-y","relation":{},"ISSN":["1365-7852","1476-5608"],"issn-type":[{"value":"1365-7852","type":"print"},{"value":"1476-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"16 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"KTM: NIDDK, Uronext, SRS Medical Systems, Prodeon, Urotronic, Boston Scientific.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All methods were carried out in accordance with relevant guidelines and regulations. The study was conducted in compliance with the Declaration of Helsinki and applicable institutional and national ethical standards. Ethical approval for this study was obtained from the Loyola University Chicago Institutional Review Board (IRB) IRB No. 215878. Written informed consent was obtained from all participants. Written informed consent was obtained from all participants for publication of identifiable images or data was obtained form the participants.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}}]}}